Galvita AG Verified listing Verified listing

  • Swiss Biotech Association
    Not a member

Galvita develops a patented and clinically validated oral drug delivery platform. The microcapsules can be loaded with active ingredients from all BCS-classes as well as peptides, and can easily be compressed into ODTs with excellent mechanical strength and very fast disintegration.

Location
Canton
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2020
  • Number of employees in Switzerland
    10-19

You may also be interested in